CATCH-UP grant provides more clinical trials to rural, underserved cancer patients
A one-year, $500,000 grant from the National Cancer Institute (NCI) will bring more clinical trial opportunities to cancer patients living in Kansas.
Leading population health expert joins cancer center
Elizabeth Calhoun, PhD, MEd, has been named professor in the department of Population Health and associate dean for population health at the University of Kansas Medical Center.
Cancer center exceeds NCORP clinical trial accrual goals
The University of Kansas Cancer Center’s status as a community site of the National Cancer Institute’s Community Oncology Research Program (NCORP) has been renewed following a successful first year.
Dr. Siddhartha Ganguly appointed to endowed professorship
Ganguly has been named the A. Drue Jennings Professor in Medical Oncology.
Researchers from the University of Kansas pivot from studying cancer and cystic fibrosis to launch trial of drug to fight COVID-19
A unique partnership between a researcher usually focused on cancer and a researcher usually focused on cystic fibrosis has resulted in an investigator-initiated clinical trial.
Scientists look to common herb to keep early-stage breast cancer from progressing
Rosemary, a fragrant herb frequently used in recipes and perfumes, may contain properties that prevent breast cancer from progressing.
Nanomaterials expert joins cancer center team
Stefan Bossmann, PhD, has joined KU Cancer Center as a member of the Drug Discovery, Delivery and Experimental Therapeutics research program.
Y-90 Radioembolization Now Offered in an Outpatient Setting
Kansas City, Kan. ― The University of Kansas Health System now offers radioembolization, also known as Y-90, as an outpatient procedure at The University of Kansas Hospital in Overland Park. Our fellowship-trained interventional radiologists speciali...
Cancer Program Recognized Among Nation’s Top 10 Percent
U.S. News & World Report released its 2020-21 Best Hospitals rankings on July 28. The cancer program at The University of Kansas Hospital is recognized among the top 10% of all hospitals in the nation. U.S. News evaluates hospitals on a series of a...
Ronald Chen named a Fellow of the American Society for Radiation Oncology
Honor recognizes exceptional service to the field of radiation oncology and cancer care
Targeting telomerase to slow cancer growth
Graduate student Matthew Schaich forges ahead with research efforts, career aspirations, despite added challenges of pandemic.
KU Cancer Center highlights from AACR Annual Meeting
The meeting featured a variety of sessions including a Clinical Plenary session, led by Weijing Sun, MD, director of Medical Oncology.
Chen Elected Co-Chair of NCI's Prostate Cancer Task Force
Task force is guided by strategic priorities, include addressing areas of unmet clinical need, unanswered clinical questions and potential new approaches to disease treatment.
KU Cancer Center at ASCO
More than 42,750 people from 138 countries attended this year’s American Society of Clinical Oncology (ASCO) annual meeting. Held virtually for the first time ever, the meeting featured 2,600 faculty and speakers and 5,300 abstracts delivering the latest news in cancer research. Members of The University of Kansas Cancer Center discussed their key findings and presented dozens of abstracts.